Trademark: 88769614
Status Date
Tuesday, December 13, 2022
Registration Number
6925350
Registration Date
Tuesday, December 13, 2022
Filing Date
Wednesday, January 22, 2020
Published for Opposition
Tuesday, May 26, 2020
35 Business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials; business consulting and management in the field of regulatory submission management, namely, clinical trial data integrity and immutability; database management in the field of clinical trials; updating and maintenance of data in computer databases in the field of clinical trials
44 Medical services, namely, medical advice relating to the design of clinical trials, late phase research, adverse event reporting and safety monitoring of clinical trials; medical services, namely, medical advice relating to long-term health management
42 Software as a service (SAAS) services featuring software for the processing and analysis of data using artificial intelligence and natural language processing; Software as a service (SAAS) services featuring software for planning, management and operational management in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software featuring machine learning technology for planning, management, operational management, and study design optimization in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software for estimating the probability of clinical trial success; Software as a service (SAAS) services featuring software featuring machine learning technology for capturing, collecting, managing, analyzing, and reporting data from clinical trials and drug discovery for use in database management and processing data; scientific consulting services in the field of conducting clinical trials for others; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial, drug development, drug discovery information; providing medical and scientific research information in the field of clinical trials; providing online searchable databases featuring medical and scientific research clinical trial information whereby users can input and collect data and information for research purposes; pharmaceutical research and development information services in the field of health care and clinical trials; Software as a service (SAAS) services featuring software for real-time and long-term patient monitoring and safety review in the field of clinical trials; Software as a service (SAAS) services featuring software for the processing and analysis of data for use in the discovery of disease biomarkers for diagnostic and therapeutic purposes; structural and functional analysis of genomes; database development services, namely, providing configuration and customization of computer databases in the field of medical information related to clinical trials and late phase research; database development services, namely, providing configuration and customization of computer databases in the field of medical information related healthcare and long-term health management; medical research, namely, compiling and analyzing genomics data for use in the discovery of disease biomarkers which are used for diagnostic and therapeutic purposes
Dec 13, 2022
Notice Of Registration Confirmation Emailed
Dec 13, 2022
Registered-Principal Register
Nov 8, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 5, 2022
Allowed Principal Register - Sou Accepted
Nov 4, 2022
Teas/Email Correspondence Entered
Nov 4, 2022
Correspondence Received In Law Office
Nov 4, 2022
Teas Response To Office Action Received
Sep 28, 2022
Notification Of Non-Final Action E-Mailed
Sep 28, 2022
Non-Final Action E-Mailed
Sep 28, 2022
Su - Non-Final Action - Written
Sep 28, 2022
Statement Of Use Processing Complete
Sep 14, 2022
Use Amendment Filed
Sep 27, 2022
Case Assigned To Intent To Use Paralegal
Sep 14, 2022
Teas Statement Of Use Received
Jul 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 8, 2022
Sou Extension 4 Granted
Jul 8, 2022
Sou Extension 4 Filed
Jul 8, 2022
Teas Extension Received
Jan 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2022
Sou Extension 3 Granted
Jan 7, 2022
Sou Extension 3 Filed
Jan 7, 2022
Teas Extension Received
Jun 5, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 3, 2021
Sou Extension 2 Granted
Jun 3, 2021
Sou Extension 2 Filed
Jun 3, 2021
Teas Extension Received
Jan 8, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 6, 2021
Sou Extension 1 Granted
Jan 6, 2021
Sou Extension 1 Filed
Jan 6, 2021
Teas Extension Received
Jul 21, 2020
Noa E-Mailed - Sou Required From Applicant
May 26, 2020
Official Gazette Publication Confirmation E-Mailed
May 26, 2020
Published For Opposition
May 6, 2020
Notification Of Notice Of Publication E-Mailed
Apr 20, 2020
Assigned To Lie
Apr 13, 2020
Letter Of Protest Evidence Reviewed-No Further Action Taken
Apr 13, 2020
Letter Of Protest Evidence Forwarded
Apr 9, 2020
Approved For Pub - Principal Register
Apr 9, 2020
Examiner's Amendment Entered
Apr 9, 2020
Notification Of Examiners Amendment E-Mailed
Apr 9, 2020
Examiners Amendment E-Mailed
Apr 9, 2020
Examiners Amendment -Written
Apr 9, 2020
Assigned To Examiner
Jan 27, 2020
New Application Office Supplied Data Entered In Tram
Jan 25, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
